<p>(A)Schematic of CD133<sup>+</sup> and CD133<sup>-/lo</sup> tumor cells sorting from dissociated colorectal xenograft tumor by FACS. (B) A representative example of post-sorting analysis of the sorted CD133<sup>+</sup> and CD133<sup>-/lo</sup> XhCRC cells.(C) Tumor-initiating frequency of CD133<sup>+</sup> and CD133<sup>-/lo</sup> CRC cells in immunodeficient mice (D-G)Serial sphere formation assays for purified CD133<sup>+</sup> and CD133<sup>-/lo</sup>CRC cells (i.e., XhCRC and SW620). Spheres were enumerated (D, F) and representative images are shown (E, G).Scale bars, 100μm.***<i>P</i>< 0.001.</p
Colon carcinoma is the second most common cause of death from cancer. The isolation and characteriza...
Objective. Stage I colorectal carcinomas display a highly variable behavior which is not accurately ...
Background: CD133 and CD44 are putative cancer stem cell (CSC) markers in colorectal cancer (CRC). H...
BACKGROUND: "Cancer stem cells" (CSC) have been identified as a minority of cancer cells responsibl...
INTRODUCTION: Recent evidence based on cancer stem cell (CSC) models, is boosting the progress of tr...
<p><i>A</i>, Schema illustrating the work flow of spheroid CSC generation and differentiated cell po...
Several surface markers have been proposed for the identification and characterization of colorectal...
Several surface markers have been proposed for the identification and characterization of colorectal...
Summary: Background/Objective: CD133 is currently considered the most robust surface marker for col...
CD133 is a membrane molecule that has been, controversially, reported as a CSC marker in colorectal ...
The cancer stem cell model suggests that only a rare subpopulation, known as cancer stem cells (CSC)...
The cancer stem cell model suggests that only a rare subpopulation, known as cancer stem cells (CSC)...
Experimental data indicate that colorectal cancer cells with CD133 expression exhibit enhanced tumor...
<p>(A) CCC stem cells were infected with a lentivirus expressing an shRNA targeting CD133. Cells wer...
Colon carcinoma is the second most common cause of death from cancer. The isolation and characteriza...
Colon carcinoma is the second most common cause of death from cancer. The isolation and characteriza...
Objective. Stage I colorectal carcinomas display a highly variable behavior which is not accurately ...
Background: CD133 and CD44 are putative cancer stem cell (CSC) markers in colorectal cancer (CRC). H...
BACKGROUND: "Cancer stem cells" (CSC) have been identified as a minority of cancer cells responsibl...
INTRODUCTION: Recent evidence based on cancer stem cell (CSC) models, is boosting the progress of tr...
<p><i>A</i>, Schema illustrating the work flow of spheroid CSC generation and differentiated cell po...
Several surface markers have been proposed for the identification and characterization of colorectal...
Several surface markers have been proposed for the identification and characterization of colorectal...
Summary: Background/Objective: CD133 is currently considered the most robust surface marker for col...
CD133 is a membrane molecule that has been, controversially, reported as a CSC marker in colorectal ...
The cancer stem cell model suggests that only a rare subpopulation, known as cancer stem cells (CSC)...
The cancer stem cell model suggests that only a rare subpopulation, known as cancer stem cells (CSC)...
Experimental data indicate that colorectal cancer cells with CD133 expression exhibit enhanced tumor...
<p>(A) CCC stem cells were infected with a lentivirus expressing an shRNA targeting CD133. Cells wer...
Colon carcinoma is the second most common cause of death from cancer. The isolation and characteriza...
Colon carcinoma is the second most common cause of death from cancer. The isolation and characteriza...
Objective. Stage I colorectal carcinomas display a highly variable behavior which is not accurately ...
Background: CD133 and CD44 are putative cancer stem cell (CSC) markers in colorectal cancer (CRC). H...